NCT05488353 2022-08-04A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial CarcinomaSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 4 Not yet recruiting48 enrolled